Juan Díaz Salazar

WORK HISTORY

EDUCATION

SKILLS

ABOUT JUAN DÍAZ SALAZAR

Experienced Endocrinologist and Internal Medicine specialist with a demostrated history of working in the hospital & health care industry for over 20 years skilled in Diabetes, Clinical Research, Medical Education and Clinical Trials.Strong healthcare services profesional with an Endocrinology, Diabetes & Metabolismo Fellow from Uniklink Düsseldorf Germany and Internal Medicine Residency from Centro Médico 20 de Noviembre México City.Professional ExperienceExperienced professional with more than 20 years in executive positions in transnational companies, have lead medical teams in the Pharmaceutical Industry.With proven skills and competences of leadership, result orientation, strategic thinking and vision, analytical, planning, motivation, team work; all within a frame of values, integrity, honesty and respect.Well recognized for integrated and developing highly motivated teams that are productive and high performance.Strenghts: Development, implementation, and management of strategic scientific platforms across therapeutic areas of importance to the company. Lead the alignment of medical strategic platforms with corporate objectives. Establish scientific education materials and ensure distribution and understanding within affiliate personal. Oversee the collaboration and coordination of meetings between affiliate and parent stakeholders (Government Affairs, Marketing and Global Medical Affairs) with national organizations to align strategic medical and scientific initiatives. Develop and maintain relationships externally through advisory board, professional associations, professional meetings and conferences, etc, to achieve the company´s scientific objectives.Major achievements:National Basic FormularyElaboration the Medical dossiers, products included: Celebrex, Tafil, Dalacin, Dostinex, Genotropin, Januvia, Fosamax, Gardasil, Vytorin, Issentres, Rotateq, Invanz, Elicuis, Onglyza, etc.Regulatory AffairsMexico was the first country of the MSD world in obtained the approval of Januvia, Rotateq, Gardasil, Cordaptive, and with Boehringer for Trayenta, and for BMS supported for Elicuis, Kombiglyze XR, Daklinza, Forxiga, etc.